FDA NDC Directory · JSON-LD · Markdown

fosaprepitant

NDC 67457-889 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerMylan Institutional LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA204015
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFOSAPREPITANT DIMEGLUMINE (150 mg/5mL)
Marketing started20190905
Package count1

External sources

Source: openFDA. Public-domain (CC0).